Literature DB >> 20960071

The Santoro III massive enterectomy: how can we justify the risks in obese adolescents?

Thomas Inge, Michael Helmrath, Mark Vierra.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20960071     DOI： 10.1007/s11695-010-0291-z

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  8 in total

1.  Beriberi after gastric bypass surgery in adolescence.

Authors:  Alexander Towbin; Thomas H Inge; Victor F Garcia; Helmut R Roehrig; Ronald H Clements; Carroll M Harmon; Stephen R Daniels
Journal:  J Pediatr       Date:  2004-08       Impact factor: 4.406

2.  No surgical innovation without evaluation: the IDEAL recommendations.

Authors:  Peter McCulloch; Douglas G Altman; W Bruce Campbell; David R Flum; Paul Glasziou; John C Marshall; Jon Nicholl; Jeffrey K Aronson; Jeffrey S Barkun; Jane M Blazeby; Isabell C Boutron; W Bruce Campbell; Pierre-Alain Clavien; Jonathan A Cook; Patrick L Ergina; Liane S Feldman; David R Flum; Guy J Maddern; Jon Nicholl; Bournaby C Reeves; Christoph M Seiler; Steven M Strasberg; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Patrick L Ergina; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Jonathan Meakins; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

3.  Evaluation and stages of surgical innovations.

Authors:  Jeffrey S Barkun; Jeffrey K Aronson; Liane S Feldman; Guy J Maddern; Steven M Strasberg; Douglas G Altman; Jeffrey S Barkun; Jane M Blazeby; Isabell C Boutron; W Bruce Campbell; Pierre-Alain Clavien; Jonathan A Cook; Patrick L Ergina; David R Flum; Paul Glasziou; John C Marshall; Peter McCulloch; Jon Nicholl; Bournaby C Reeves; Christoph M Seiler; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

4.  Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass.

Authors:  Thomas H Inge; Todd M Jenkins; Meg Zeller; Lawrence Dolan; Stephen R Daniels; Victor F Garcia; Mary L Brandt; Judy Bean; Kimberlee Gamm; Stavra A Xanthakos
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

5.  Ethical issues in pediatric bariatric surgery.

Authors:  Donna A Caniano
Journal:  Semin Pediatr Surg       Date:  2009-08       Impact factor: 2.754

6.  Late intestinal obstruction due to an intestinal volvulus in a pregnant patient with a previous Roux-en-Y gastric bypass.

Authors:  Anajara Gazzalle; Débora Braun; Leandro Totti Cavazzola; Luiz Roberto Wendt; Daniel Navarini; Marcelo de Azevedo Fauri; Santo Pascual Vitola
Journal:  Obes Surg       Date:  2009-03-25       Impact factor: 4.129

7.  Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.

Authors:  Stavros N Karamanakos; Konstantinos Vagenas; Fotis Kalfarentzos; Theodore K Alexandrides
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

8.  Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases.

Authors:  Sérgio Santoro; Fábio Quirilo Milleo; Carlos Eduardo Malzoni; Sidney Klajner; Pedro C M Borges; Marco Aurélio Santo; Fábio Guilherme Campos; Roberto Ferreira Artoni
Journal:  Obes Surg       Date:  2007-12-15       Impact factor: 4.129
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.